Literature DB >> 12450285

Neuronal survival following remote adenovirus gene delivery.

Nicholas M Boulis1, Danielle E Turner, Michael J Imperiale, Eva L Feldman.   

Abstract

OBJECT: Virus-mediated central nervous system gene delivery is a promising means of treating traumatized tissue or degenerative diseases. In the present study, the authors examined gene expression and neuronal survival in the spinal cord after sciatic nerve administration of an adenovirus vector expressing a LacZ reporter gene.
METHODS: The time course of adenovirus gene expression, DNA fragmentation, and neuronal density were quantified in rat lumbar spinal cord by staining for beta-galactosidase (beta-Gal), terminal deoxynucleotidyl transferase, and cresyl violet after microinjection of either saline or the reporter virus into rat sciatic nerve. The expression of beta-Gal following remote vector delivery peaked at 7 days and declined thereafter but was not accompanied by neuronal cell death, as measured by DNA fragmentation. No significant difference in spinal motor neuron density was detected between virus-treated and control rats at any time point examined. Although the spinal cords removed from rats treated with cyclosporine prior to adenovirus injection contained substantially more neurons staining for beta-Gal at 7 days (67% of total neurons), the decay in the number of stained neurons was not paralleled by a decline in motor neuron density.
CONCLUSIONS: The authors conclude that remote gene expression is suppressed by a noncytolytic process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12450285     DOI: 10.3171/spi.2002.96.2.0212

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

1.  Lentiviral vector mediates exogenous gene expression in adult rat DRG following peripheral nerve remote delivery.

Authors:  Ping Yang
Journal:  J Mol Neurosci       Date:  2012-02-09       Impact factor: 3.444

2.  Modification of Schwann cell gene expression by electroporation in vivo.

Authors:  Manuela Aspalter; Alka Vyas; Jeffrey Feiner; John Griffin; Thomas Brushart; Richard Redett
Journal:  J Neurosci Methods       Date:  2008-09-11       Impact factor: 2.390

Review 3.  Strategic approaches to developing drug treatments for ALS.

Authors:  Andrea M Vincent; Stacey A Sakowski; Adam Schuyler; Eva L Feldman
Journal:  Drug Discov Today       Date:  2007-11-26       Impact factor: 7.851

4.  Neuromuscular effects of G93A-SOD1 expression in zebrafish.

Authors:  Stacey A Sakowski; J Simon Lunn; Angela S Busta; Sang Su Oh; Grettel Zamora-Berridi; Madeline Palmer; Andrew A Rosenberg; Stephen G Philip; James J Dowling; Eva L Feldman
Journal:  Mol Neurodegener       Date:  2012-08-31       Impact factor: 14.195

5.  Gene therapy: a potential approach for cancer pain.

Authors:  Chalonda R Handy; Christina Krudy; Nicholas Boulis
Journal:  Pain Res Treat       Date:  2011-06-09

6.  The role of oxidative stress in nervous system aging.

Authors:  Catrina Sims-Robinson; Junguk Hur; John M Hayes; Jacqueline R Dauch; Peter J Keller; Susan V Brooks; Eva L Feldman
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

7.  Targeting Motor End Plates for Delivery of Adenoviruses: An Approach to Maximize Uptake and Transduction of Spinal Cord Motor Neurons.

Authors:  Andrew Paul Tosolini; Renée Morris
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

Review 8.  Targeting immune checkpoints in malignant glioma.

Authors:  Xuhao Zhang; Shan Zhu; Tete Li; Yong-Jun Liu; Wei Chen; Jingtao Chen
Journal:  Oncotarget       Date:  2017-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.